160 related articles for article (PubMed ID: 36856395)
1. The impact of haematoxylin-eosin staining and immunohistochemistry of lentigo maligna and lentigo maligna melanoma margins on local recurrence.
Eckardt J; Behrens V; Kofler K; Forchhammer S; Häfner HM; Kofler L
Eur J Dermatol; 2022 Nov; 32(6):750-755. PubMed ID: 36856395
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
[TBL] [Abstract][Full Text] [Related]
3. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up.
Bub JL; Berg D; Slee A; Odland PB
Arch Dermatol; 2004 May; 140(5):552-8. PubMed ID: 15148099
[TBL] [Abstract][Full Text] [Related]
4. Clinical features associated with the invasive component in lentigo maligna of the head and neck: A retrospective study of 175 cases.
Gérard E; Cogrel O; Goehrs C; Guillot P; Ricard A; Pham-Ledard A; Dutriaux C; Pinsolle V; Vergier B; Beylot-Barry M
Ann Dermatol Venereol; 2022 Dec; 149(4):258-263. PubMed ID: 35738946
[TBL] [Abstract][Full Text] [Related]
5. Double Immunohistochemical Labelling of PRAME and Melan A in Slow Mohs Biopsy Margin Assessment of Lentigo Maligna and Lentigo Maligna Melanoma.
Salih R; Ismail F; Orchard GE
Br J Biomed Sci; 2024; 81():12319. PubMed ID: 38566933
[No Abstract] [Full Text] [Related]
6. Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre.
Collgros H; Rodriguez-Lomba E; Regio Pereira A; Lo SN; Scolyer RA; Guitera P
J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):1315-1322. PubMed ID: 33502077
[TBL] [Abstract][Full Text] [Related]
7. Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma.
Dika E; Lambertini M; Patrizi A; Misciali C; Scarfì F; Pellacani G; Mandel VD; Di Tullio F; Stanganelli I; Chester J; Kaleci S; Massi D; De Giorgi V; Cinotti E; Rubegni P; Perrot JL; Farnetani F
J Dtsch Dermatol Ges; 2021 Feb; 19(2):223-229. PubMed ID: 33166059
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of formalin-fixed Mohs surgery and haematoxylin and eosin stains with control contralateral biopsies for lentigo maligna: 5-year follow-up results.
Lawrence CM; Rahim R; Charlton F; Husain A
Br J Dermatol; 2014 Aug; 171(2):298-303. PubMed ID: 24446749
[TBL] [Abstract][Full Text] [Related]
9. Mohs surgery for the treatment of lentigo maligna and lentigo maligna melanoma - a systematic review.
Sharma AN; Foulad DP; Doan L; Lee PK; Atanaskova Mesinkovska N
J Dermatolog Treat; 2021 Mar; 32(2):157-163. PubMed ID: 31696746
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience.
Bhardwaj SS; Tope WD; Lee PK
Dermatol Surg; 2006 May; 32(5):690-6; discussion 696-7. PubMed ID: 16706765
[TBL] [Abstract][Full Text] [Related]
11. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
Walling HW; Scupham RK; Bean AK; Ceilley RI
J Am Acad Dermatol; 2007 Oct; 57(4):659-64. PubMed ID: 17870430
[TBL] [Abstract][Full Text] [Related]
12. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: an update from the University of Minnesota.
Newman J; Beal M; Schram SE; Lee PK
Dermatol Surg; 2013 Dec; 39(12):1794-9. PubMed ID: 24164856
[TBL] [Abstract][Full Text] [Related]
13. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
Ren M; Kong YY; Shen XX; Cai X; Kong JC
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
[No Abstract] [Full Text] [Related]
14. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
[TBL] [Abstract][Full Text] [Related]
15. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.
Guitera P; Collgros H; Madronio CM; Goumas C; Mann GJ; Watts CG; Pereira AR; Armstrong BK; Drummond M; Morton RL; Scolyer RA; Menzies SW; Thompson JF; Cust AE
Australas J Dermatol; 2019 May; 60(2):118-125. PubMed ID: 30302753
[TBL] [Abstract][Full Text] [Related]
16. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.
Yélamos O; Cordova M; Blank N; Kose K; Dusza SW; Lee E; Rajadhyaksha M; Nehal KS; Rossi AM
JAMA Dermatol; 2017 Dec; 153(12):1278-1284. PubMed ID: 29049429
[TBL] [Abstract][Full Text] [Related]
18. Locally Recurrent Lentigo Maligna and Lentigo Maligna Melanoma: Characteristics and Time to Recurrence After Surgery.
Connolly KL; Hibler BP; Lee EH; Rossi AM; Busam KJ; Nehal KS
Dermatol Surg; 2017 Jun; 43(6):792-797. PubMed ID: 28296789
[TBL] [Abstract][Full Text] [Related]
19. Comparison of surgical margins for lentigo maligna versus melanoma in situ.
Kunishige JH; Doan L; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2019 Jul; 81(1):204-212. PubMed ID: 31014825
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
Bowen AR; Thacker BN; Goldgar DE; Bowen GM
Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
